Connection

Kwok-Yung Yuen to Viral Load

Back to Details
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Viral Load.
Kwok-Yung Yuen
Connection Strength
1.574
Viral Load
  1. Comparative evaluation of a laboratory-developed real-time PCR assay and RealStar® Adenovirus PCR Kit for quantitative detection of human adenovirus. Virol J. 2018 09 27; 15(1):149.
    View in: PubMed
    Score: 0.171
  2. Additional molecular testing of saliva specimens improves the detection of respiratory viruses. Emerg Microbes Infect. 2017 Jun 07; 6(6):e49.
    View in: PubMed
    Score: 0.156
  3. Viral loads in clinical specimens and SARS manifestations. Hong Kong Med J. 2009 Dec; 15 Suppl 9:20-2.
    View in: PubMed
    Score: 0.093
  4. Initial viral load and the outcomes of SARS. CMAJ. 2004 Nov 23; 171(11):1349-52.
    View in: PubMed
    Score: 0.065
  5. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004 Sep; 10(9):1550-7.
    View in: PubMed
    Score: 0.064
  6. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Clin Infect Dis. 2020 12 03; 71(9):2428-2446.
    View in: PubMed
    Score: 0.050
  7. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2020 11 19; 71(16):2139-2149.
    View in: PubMed
    Score: 0.050
  8. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters. Cell Rep Med. 2020 10 20; 1(7):100121.
    View in: PubMed
    Score: 0.049
  9. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2. Nat Commun. 2020 08 25; 11(1):4252.
    View in: PubMed
    Score: 0.049
  10. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis. 2020 07 28; 71(15):841-843.
    View in: PubMed
    Score: 0.048
  11. SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series. Lancet Infect Dis. 2020 09; 20(9):1051-1060.
    View in: PubMed
    Score: 0.048
  12. Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2020 11; 41(11):1258-1265.
    View in: PubMed
    Score: 0.048
  13. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol Res. 2020 09; 159:104960.
    View in: PubMed
    Score: 0.048
  14. Infection of bat and human intestinal organoids by SARS-CoV-2. Nat Med. 2020 07; 26(7):1077-1083.
    View in: PubMed
    Score: 0.048
  15. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020 05; 20(5):565-574.
    View in: PubMed
    Score: 0.047
  16. Detection of norovirus in air samples in a non-vomiting patient: implications of testing saliva for norovirus in an immunocompromised host. J Hosp Infect. 2019 Nov; 103(3):357-358.
    View in: PubMed
    Score: 0.045
  17. Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant. Emerg Infect Dis. 2018 12; 24(12):2241-2250.
    View in: PubMed
    Score: 0.043
  18. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. Antiviral Res. 2018 12; 160:38-47.
    View in: PubMed
    Score: 0.043
  19. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong. J Viral Hepat. 2018 02; 25(2):209-213.
    View in: PubMed
    Score: 0.040
  20. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Antiviral Res. 2017 Sep; 145:33-43.
    View in: PubMed
    Score: 0.039
  21. Comparative evaluation of a laboratory developed real-time PCR assay and the RealStar® HHV-6 PCR Kit for quantitative detection of human herpesvirus 6. J Virol Methods. 2017 08; 246:112-116.
    View in: PubMed
    Score: 0.039
  22. Anaconda paramyxovirus infection in an adult green anaconda after prolonged incubation: Pathological characterization and whole genome sequence analysis. Infect Genet Evol. 2017 07; 51:239-244.
    View in: PubMed
    Score: 0.039
  23. Treatment With Lopinavir/Ritonavir or Interferon-ß1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015 Dec 15; 212(12):1904-13.
    View in: PubMed
    Score: 0.034
  24. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect. 2013 Dec; 67(6):606-16.
    View in: PubMed
    Score: 0.030
  25. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013 Dec; 94(Pt 12):2679-2690.
    View in: PubMed
    Score: 0.030
  26. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis. 2013 Jun 01; 207(11):1743-52.
    View in: PubMed
    Score: 0.029
  27. Duration of RT-PCR positivity in severe acute respiratory syndrome. Eur Respir J. 2005 Jan; 25(1):12-4.
    View in: PubMed
    Score: 0.016
  28. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24; 361(9371):1767-72.
    View in: PubMed
    Score: 0.015
  29. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerg Microbes Infect. 2021 Dec; 10(1):291-304.
    View in: PubMed
    Score: 0.013
  30. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies. Cell Host Microbe. 2021 04 14; 29(4):551-563.e5.
    View in: PubMed
    Score: 0.013
  31. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat Microbiol. 2020 11; 5(11):1439-1448.
    View in: PubMed
    Score: 0.012
  32. Case of "relapsing" COVID-19 in a kidney transplant recipient. Nephrology (Carlton). 2020 Dec; 25(12):933-936.
    View in: PubMed
    Score: 0.012
  33. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19). Viruses. 2020 06 10; 12(6).
    View in: PubMed
    Score: 0.012
  34. Vedolizumab-mediated integrin a4ß7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice. AIDS. 2019 03 15; 33(4):F1-F12.
    View in: PubMed
    Score: 0.011
  35. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. J Infect Dis. 2018 07 02; 218(3):365-377.
    View in: PubMed
    Score: 0.011
  36. A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci Rep. 2016 Feb 25; 6:22008.
    View in: PubMed
    Score: 0.009
  37. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar; 59(3):252-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.